BioNexus Gene Lab Corp. (BGLC) Gross profit 2018–2025
BioNexus Gene Lab Corp. (BGLC) annual gross profit history from SEC filings — each fiscal year as reported.
$1.1MFY2025 · since FY2018: $28,765 → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1M | -15.8% |
| FY2024 | $1.3M | -3.0% |
| FY2023 | $1.3M | +5.6% |
| FY2022 | $1.3M | -44.5% |
| FY2021 | $2.3M | +31.8% |
| FY2020 | $1.7M | +2977.3% |
| FY2019 | $55,888 | +94.3% |
| FY2018 | $28,765 | — |
Source: SEC XBRL filings · For reference only · Not investment advice